PD-1 Inhibitor Enhanced Radiosensitivity by Reactivating T Cells and Inducing G2/M Phase Arrest in Esophageal Squamous Cell Carcinoma | Citedby Results | Radiation Research

Skip to Main Content

Skip Nav Destination

PD-1 Inhibitor Enhanced Radiosensitivity by Reactivating T Cells and Inducing G2/M Phase Arrest in Esophageal Squamous Cell Carcinoma

Radiat Res (2022) 198 (5): 458–466.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Induction sintilimab and chemotherapy followed by concurrent chemoradiotherapy for locally advanced esophageal cancer: a proof-of-concept, single-arm, multicenter, phase 2 trial

Dashan Ai
Shengnan Hao
Wenbin Shen
Qibing Wu
Shengjian Zhang
Yun Chen
Qi Liu
Jiaying Deng
Hongcheng Zhu
Ke Chen
Miao Mo
Dayong Gu
Yatian Liu
Zhi Zhang
Guoren Zhou
Jingwen Hu
Zhen Zhang
Jinjun Ye
Kuaile Zhao

eClinicalMedicine (2024) 69: 102471.

Mechanisms of radiotherapy resistance and radiosensitization strategies for esophageal squamous cell carcinoma

Lingbo An
Mingyang Li
Qingge Jia

Molecular Cancer (2023) 22 (1)

Early low blood MALT1 expression levels forecast better efficacy of PD‑1 inhibitor‑based treatment in patients with metastatic colorectal cancer

Chuanming Li
Fan Yu
Wanli Xu

Oncology Letters (2023) 26 (2)